Oklahoma Cardiovascular & Hypertension — Oklahoma City, Oklahoma

Oklahoma Cardiovascular & Hypertension is a clinical research site located in Oklahoma City, Oklahoma, United States 73132.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Oklahoma Cardiovascular & Hypertension has participated in 2 clinical trials.

Therapeutic areas: Angina Pectoris, Hypertension.

Sponsors: Tasly Pharmaceuticals, Inc., Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oklahoma Cardiovascular & Hypertension?

Oklahoma Cardiovascular & Hypertension has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oklahoma Cardiovascular & Hypertension conducted?

Oklahoma Cardiovascular & Hypertension has 2 clinical trials on record. Their work covers Angina Pectoris, Hypertension.

Is Oklahoma Cardiovascular & Hypertension accredited by Crixeo Clinical Trials?

Oklahoma Cardiovascular & Hypertension has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oklahoma Cardiovascular & Hypertension?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.